ArticleOncology letters2018

Potent antitumor effect of combination therapy with sub-optimal doses of Akt inhibitors and pomalidomide plus dexamethasone in multiple myeloma.

Shiori Kinoshita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.